MARKET

TNDM

TNDM

Tandem Diabetes
NASDAQ

Real-time Quotes | Nasdaq Last Sale

94.67
-1.35
-1.41%
After Hours: 94.70 +0.03 +0.03% 19:59 12/04 EST
OPEN
95.96
PREV CLOSE
96.02
HIGH
96.13
LOW
93.40
VOLUME
895.81K
TURNOVER
--
52 WEEK HIGH
123.74
52 WEEK LOW
43.69
MARKET CAP
5.89B
P/E (TTM)
-117.5149
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Medtronic Sees a Recovery. Disruptive Opportunities Are Next.
The pandemic interrupted sales for medical-device companies but the company said Tuesday that revenues recovered faster than expected in the October quarter.
Barrons.com · 11/24 19:19
Tandem Diabetes' (TNDM) Insulin Pump Approved by Health Canada
Tandem Diabetes' (TNDM) t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology cleared for use in Canada post the receipt of Health Canada approval.
Zacks · 11/24 14:16
Health Canada OKs Tandem Diabetes' t:slim X2 insulin pump
Health Canada has approved Tandem Diabetes Care's (TNDM) t:slim X2 insulin pump with Control-IQ technology. All in-warranty t:slim X2 pump users in Canada will have the option to add Control-IQ
Seekingalpha · 11/24 10:29
Tandem Diabetes Care Announces Health Canada Approval Of The t:slim X2 Insulin Pump With Control-IQ Advanced Hybrid Closed-Loop Technology
Tandem Diabetes Care Announces Health Canada Approval of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and
Benzinga · 11/23 14:05
Tandem Diabetes Care Announces Health Canada Approval of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada approval of the t:slim X2(TM) insulin pump with Control-IQ(TM) technology. Control-IQ technology is an advanced hybrid closed-loop feature designed to help increase time in range (3.9-10 mmol/L)(1) and deliver automatic correction boluses in addition to adjusting insulin to help prevent high and low blood sugar. The system integrates with Dexcom G6 continuous glucose monitoring (CGM), which requires no fingersticks for calibration or diabetes treatment decisions.(2,3,4)
BusinessWire · 11/23 11:00
Zacks.com featured highlights include: The New York Times, Apple and Tandem Diabetes Care
Zacks.com featured highlights include: The New York Times, Apple and Tandem Diabetes Care
Zacks · 11/09 14:27
Tandem Diabetes Care, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / November 5, 2020 / Tandem Diabetes Care, Inc. (NASDAQ:TNDM) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 5, 2020 at 4:30 PM Eastern Time.
ACCESSWIRE · 11/05 19:47
Tandem Diabetes Care, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / November 5, 2020 / Tandem Diabetes Care, Inc.
ACCESSWIRE · 11/05 19:45
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of TNDM. Analyze the recent business situations of Tandem Diabetes through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 15 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average TNDM stock price target is 129.13 with a high estimate of 140.00 and a low estimate of 99.00.
EPS
Institutional Holdings
Institutions: 460
Institutional Holdings: 62.82M
% Owned: 101.00%
Shares Outstanding: 62.19M
TypeInstitutionsShares
Increased
110
4.87M
New
86
156.23K
Decreased
112
5.69M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.48%
Healthcare Equipment & Supplies
+1.33%
Key Executives
Chairman/Director
Kim Blickenstaff
President/Chief Executive Officer/Director
John Sheridan
Chief Financial Officer/Executive Vice President/Treasurer
Leigh Vosseller
Executive Vice President/Chief Administrative Officer
Susan Morrison
Executive Vice President/Chief Compliance Officer/Secretary
David Berger
Executive Vice President
Elizabeth Gasser
Executive Vice President
Brian Hansen
Lead Director/Independent Director
Dick Allen
Independent Director
Edward Cahill
Independent Director
Peyton Howell
Independent Director
Kathleen McGroddy-Goetz
Independent Director
Rebecca Robertson
Independent Director
Douglas Roeder
Independent Director
Christopher Twomey
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About TNDM
Tandem Diabetes Care, Inc. is a medical device company engaged in the designing, developing and commercialization of products for people with insulin-dependent diabetes. The Company’s manufacturing, sales and support activities principally focus on its flagship pump platform, the t:slim X2 Insulin Delivery System (t:slim X2), and its product offerings. The t:slim X2 is based on its technology platform and is capable of remote feature updates and is designed to display continuous glucose monitoring (CGM) sensor information directly on the pump home screen. Its products also include Basal-IQ technology and Control-IQ technology. The Basal-IQ technology is a predictive low glucose suspend feature that is designed to temporarily suspend insulin delivery to help reduce the frequency and duration of hypoglycemic events. The Control-IQ technology is a hybrid-closed loop feature, designed to help increase a user's time in targeted glycemic range.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Tandem Diabetes Care Inc stock information, including NASDAQ:TNDM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNDM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TNDM stock methods without spending real money on the virtual paper trading platform.